We are live on ! Find out more
HPG

Harvest Portfolios Group Portfolio holdings

AUM $7.09B
1-Year Est. Return 20.73%
This Fund
S&P 500
This Quarter Est. Return
-2.42%
1 Year Est. Return
+20.73%
3 Year Est. Return
+67.09%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.12B
AUM Growth
-$61.3M
Cap. Flow
+$8.97M
Cap. Flow %
0.42%
Top 10 Hldgs %
27.01%
Holding
230
New
15
Increased
79
Reduced
119
Closed
12
Avg Time Held
2.5 quarters
Top 10 Avg Time Held
1.1 quarters
Top 20 Avg Time Held
2.9 quarters

Top Buys

Rank Stock Value
1
A icon
Agilent Technologies
A
+$51.2M
2
AMAT icon
Applied Materials
AMAT
+$19.1M
3
COST icon
Costco
COST
+$18M
4
BMY icon
Bristol-Myers Squibb
BMY
+$8.51M
5
ISRG icon
Intuitive Surgical
ISRG
+$6.11M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$45.9M
2
QCOM icon
Qualcomm
QCOM
+$16.7M
3
DIS icon
Walt Disney
DIS
+$15.7M
4
LLY icon
Eli Lilly
LLY
+$8.62M
5
NVDA icon
NVIDIA
NVDA
+$5.96M

Sector Composition

Rank Sector Weight
1 Healthcare 50.85%
2 Technology 18.9%
3 Financials 7.4%
4 Consumer Discretionary 5.83%
5 Communication Services 4.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
UNH icon
1
UnitedHealth
UNH
$334B
$71.9M 3.39%
142,587
-7,639
-5% -$3.76M
2022 Q4
3 quarters
JNJ icon
2
Johnson & Johnson
JNJ
$617B
$67.6M 3.19%
434,191
+3,822
+0.9% +$631K
2022 Q4
3 quarters
AMGN icon
3
Amgen
AMGN
$218B
$59M 2.79%
219,556
-5,980
-3% -$1.49M
2022 Q4
3 quarters
ABBV icon
4
AbbVie
ABBV
$464B
$54.6M 2.58%
366,248
+6,266
+2% +$920K
2022 Q4
3 quarters
AZN icon
5
AstraZeneca
AZN
$243B
$53.8M 2.54%
397,017
+41,112
+12% +$5.62M
2022 Q4
3 quarters
BSX icon
6
Boston Scientific
BSX
$61.7B
$53.6M 2.53%
1,014,749
+20,969
+2% +$1.1M
2022 Q4
3 quarters
REGN icon
7
Regeneron Pharmaceuticals
REGN
$75.7B
$53.2M 2.51%
64,602
-4,659
-7% -$3.66M
2022 Q4
3 quarters
MRK icon
8
Merck
MRK
$356B
$52.9M 2.5%
514,151
+52,886
+11% +$5.7M
2022 Q4
3 quarters
BMY icon
9
Bristol-Myers Squibb
BMY
$125B
$52.8M 2.49%
909,437
+138,917
+18% +$8.51M
2022 Q4
3 quarters
NVS icon
10
Novartis
NVS
$268B
$52.7M 2.49%
517,617
+28,079
+6% +$2.85M
2022 Q4
3 quarters
LLY icon
11
Eli Lilly
LLY
$1.02T
$51.5M 2.43%
95,956
-16,719
-15% -$8.62M
2022 Q4
3 quarters
ISRG icon
12
Intuitive Surgical
ISRG
$138B
$51.2M 2.42%
175,264
+19,564
+13% +$6.11M
2022 Q4
3 quarters
ZTS icon
13
Zoetis
ZTS
$28.8B
$51.1M 2.41%
293,881
-9,322
-3% -$1.69M
2022 Q4
3 quarters
SYK icon
14
Stryker
SYK
$106B
$51M 2.41%
186,786
+8,077
+5% +$2.32M
2022 Q4
3 quarters
DHR icon
15
Danaher
DHR
$150B
$50.8M 2.4%
231,106
-13,617
-6% -$3.04M
2022 Q4
3 quarters
ELV icon
16
Elevance Health
ELV
$83.8B
$50M 2.36%
114,717
-4,361
-4% -$1.98M
2022 Q4
3 quarters
TMO icon
17
Thermo Fisher Scientific
TMO
$242B
$49.5M 2.33%
97,699
+3,476
+4% +$1.85M
2022 Q4
3 quarters
MDT icon
18
Medtronic
MDT
$110B
$49.3M 2.33%
628,656
+60,063
+11% +$5.03M
2022 Q4
3 quarters
ABT icon
19
Abbott
ABT
$169B
$49M 2.31%
506,041
+34,041
+7% +$3.58M
2022 Q4
3 quarters
A icon
20
Agilent Technologies
A
$47.3B
$47.7M 2.25%
+426,938
New +$51.2M
2023 Q3
0 quarters
ACN icon
21
Accenture
ACN
$122B
$37.6M 1.78%
122,591
-2,957
-2% -$932K
2022 Q4
3 quarters
GOOGL icon
22
Alphabet (Google) Class A
GOOGL
$4.2T
$36.9M 1.74%
282,079
-30,553
-10% -$3.95M
2022 Q4
3 quarters
MSFT icon
23
Microsoft
MSFT
$3.84T
$36.7M 1.73%
116,359
+3,833
+3% +$1.27M
2022 Q4
3 quarters
TXN icon
24
Texas Instruments
TXN
$268B
$34.3M 1.62%
215,889
+12,172
+6% +$2.08M
2022 Q4
3 quarters
AAPL icon
25
Apple
AAPL
$4.87T
$29.5M 1.39%
172,262
-29,733
-15% -$5.45M
2022 Q4
3 quarters
1
2 3 4 5

Similar funds

CGPCS
Capital Group Private Client Services Los Angeles, California $7.09B AUM 30.53% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
SAM
Scopus Asset Management New York $7.11B AUM 32.62% 1-Year Est. Return
EWM
Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return
BFS
Bradley Foster & Sargent Hartford, Connecticut $7.06B AUM 27.24% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $7.06B AUM 36.47% 1-Year Est. Return
AS
Aware Super Sydney, Australia $7.06B AUM

Harvest Portfolios Group's Q3 2023 Portfolio in Review

As of Q3 2023, Harvest Portfolios Group held 230 positions worth $2.12B, down 2.8% from $2.18B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Harvest Portfolios Group's Q3 2023 filing shows 15 new, 79 increased, 119 reduced and 12 closed positions. Its largest new stake was Agilent Technologies: 426,938 shares worth $47.7M. The largest sale was Pfizer, an estimated $45.9M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 49% a quarter earlier, followed by Technology and Financials.

  • Harvest Portfolios Group's largest Q3 2023 buy was Agilent Technologies: 426,938 shares worth $47.7M.
  • Harvest Portfolios Group added most to Bristol-Myers Squibb in Q3 2023, an estimated $8.51M increase.
  • Harvest Portfolios Group's biggest Q3 2023 reduction was Pfizer, cutting an estimated $45.9M.
  • Harvest Portfolios Group fully exited Qualcomm in Q3 2023, selling an estimated $16.7M.
  • Harvest Portfolios Group's ten largest holdings make up 27% of its $2.12B portfolio in Q3 2023.
  • Harvest Portfolios Group opened 15 new positions and closed 12 in Q3 2023.
  • Harvest Portfolios Group's portfolio value fell 2.8% quarter-over-quarter to $2.12B.

Based on Harvest Portfolios Group's 13F filing for Q3 2023, filed 2 Nov 2023.